hormone-therapy

Documents about hormone-therapy

• ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly#980992ClinicalTrials.gov
• Impact of Gender-Affirming Hormone Therapy on Dry Eye#1001599ODU Digital Commons
• An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS#869617ClinicalTrials.gov
• MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy#859880ClinicalTrials.gov
• FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial#896776ClinicalTrials.gov
• Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy#900710ClinicalTrials.gov
• Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15#813611ClinicalTrials.gov
• Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis#995115ClinicalTrials.gov
• Supplemental Material for: Persistent Elevation of Thyroid-Stimulating Hormone Despite Levothyroxine Therapy Revealing Autoimmune Adrenal Insufficiency in an Adolescent With Autoimmune Thyroiditis: A Case Report and Review of Literature#480342Figshare
• Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer#858980ClinicalTrials.gov
• Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy#865620ClinicalTrials.gov
• Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel#884095ClinicalTrials.gov
• Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial#883773ClinicalTrials.gov
• Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia#854698ClinicalTrials.gov
• Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer#896428ClinicalTrials.gov
• Evaluation of Women With Endocrine and Reproductive-Related Conditions#915390ClinicalTrials.gov
• S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy#994082ClinicalTrials.gov
• The Effect of Nutritional Formula Supplementation on Linear Growth of Growth Hormone (GH) Treated Prepubertal Children With Idiopathic Short Stature (ISS) After 2 Years From the Beginning of GH-therapy#1008337ClinicalTrials.gov
• Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer#827701ClinicalTrials.gov
• Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy#966629ClinicalTrials.gov
• Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases#917932ClinicalTrials.gov
• Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer#831321ClinicalTrials.gov
• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer#832870ClinicalTrials.gov
• Which drugs are risk factors for the development of gastroesophageal reflux disease?#954937Koc University Digital Collections
• Prevalencia de síntomas ansiosos y depresivos en usuarios del programa POLITRANS del Hospital San Ignacio en el contexto de la terapia de reemplazo hormonal#431623Repositorio Institucional Javeriano
• A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer#353297ClinicalTrials.gov
• Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy#28567ClinicalTrials.gov
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy#919064ClinicalTrials.gov
• A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)#813565ClinicalTrials.gov
• S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy#861769ClinicalTrials.gov
• Evaluating the Effects of Hormone Replacement Therapy on Brain Function (The WHIMS-MRI Study)#900242ClinicalTrials.gov
• Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery#895059ClinicalTrials.gov
• Does Menopausal Hormone Therapy, Exercise, or Both Improve Pain and Function in Postmenopausal Women With Greater Trochanteric Pain Syndrome? A 2 × 2 Factorial Randomized Clinical Trial#414752Figshare
• Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer#918714ClinicalTrials.gov
• Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors#1008794ClinicalTrials.gov
• A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting#1009753ClinicalTrials.gov
• St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer#848468ClinicalTrials.gov
• Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study#859893ClinicalTrials.gov
• Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy#1009980ClinicalTrials.gov
• Contemporary dialogues in health sciences#928238Repositório Institucional da UFMG